PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.50
-3.30% today
Updated 2026-04-29
Market cap
$2.13B
P/E ratio
23.23
P/S ratio
1.45x
EPS (TTM)
$2.26
Dividend yield
0.88%
52W range
$18 – $60
Volume
0.3M
Phibro Animal Health Corporation (PAHC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
6.29%
Operating margin
14.70%
ROE
31.80%
ROA
8.34%
Debt/equity
1.82x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $398.40M | $-13.10M | 22.87% | 5.77% | -3.29% |
| 2007 | $453.00M | $-6.70M | 24.55% | 4.66% | -1.48% |
| 2008 | $511.40M | $2.20M | 23.80% | 5.73% | 0.43% |
| 2009 | $537.10M | $-8.30M | 24.13% | 7.71% | -1.55% |
| 2010 | $594.20M | $42.10M | 26.04% | 8.89% | 7.09% |
| 2011 | $618.33M | $-12.92M | 23.72% | 6.67% | -2.09% |
| 2012 | $654.10M | $6.98M | 25.09% | 7.54% | 1.07% |
| 2013 | $653.15M | $24.89M | 27.40% | 8.69% | 3.81% |
| 2014 | $691.90M | $-3.10M | 30.03% | 9.22% | -0.45% |
| 2015 | $748.59M | $60.28M | 31.58% | 11.71% | 8.05% |
| 2016 | $751.50M | $82.70M | 31.80% | 11.40% | 11.00% |
| 2017 | $764.30M | $64.60M | 32.49% | 12.81% | 8.45% |
| 2018 | $820.00M | $64.90M | 32.55% | 12.06% | 7.91% |
| 2019 | $828.00M | $54.70M | 31.96% | 8.85% | 6.61% |
| 2020 | $800.35M | $33.55M | 32.10% | 8.65% | 4.19% |
| 2021 | $833.35M | $54.38M | 32.56% | 8.98% | 6.53% |
| 2022 | $942.26M | $49.17M | 30.29% | 8.38% | 5.22% |
| 2023 | $977.89M | $32.61M | 30.50% | 7.35% | 3.33% |
| 2024 | $1.02B | $2.42M | 30.77% | 5.24% | 0.24% |
| 2025 | $1.30B | $48.26M | 30.85% | 8.52% | 3.72% |